Endpoints
tumor
SECONDARY, TUMOR
The trial’s primary endpoints were the FMI detection rate of tumor-positive surgical margins and the cut-off value for SBR that can be used for intraoperative detection of tumor-positive margins. The secondary endpoints were the detection rates of close surgical margins, the in vivo fluorescence contrast between tumor and adjacent tissue as determined by MDSFR/SFF defined as TBR